Jeff Sessions Admits Marijuana May Have Medical Benefits, But Disagrees It Could Be an Opioid Alternative

Attorney General Jeff Sessions is not known for being very rational when it comes to marijuana, but in a recent statement he actually provided a glimpse that he may be somewhat open on the issue. But then he completely shut that door.

Sessions appeared in front of the Senate Appropriations Committee to discuss marijuana research and other issues related to cannabis. During his testimony, Sessions made a somewhat surprising admission that “there may well be some benefits from medical marijuana” and said it's “perfectly appropriate to study” cannabis. 

But that was about the extent to which Sessions approved of marijuana. Sessions says he still doesn't think it's a good to use medical cannabis. He said, “Medical marijuana, as one physician told me, ‘whoever heard of taking a medicine when you have no idea how much medicine you’re taking and ingesting it in the fashion that it is, which is in itself unhealthy?'”

At another point in his testimony, a senator brought up a recent study showing that opioid deaths were lower in states with legalized marijuana. Sessions said that he is aware of this study, but he says that he does not think that will continue.

"I’ve asked my staff to take a look at it because science is very important, and I don't believe that will be sustained in the long run," Sessions said.

So...basically there's been no progress in Session's views on marijuana. Not terribly surprising.

(h/t Marijuana Moment and Washington Examiner)

Latest.

With so much buzz around the expansion of the cannabis industry, a number of heavy-weight investors and brands are making headway in the space. Civilized teamed up with Thomas George, stock expert and president of Grizzle, at Grit Island Investment Conference in the Bahamas to learn about what's next for cannabis, what investors are looking for, international opportunities, and developing interest in auxiliary industries like CBD. We also got the 411 on cannabis titan Aurora's latest acquisitions, as well as on New York's proposed adult use marijuana program.

Can we see some ID please?

You must be 19 years of age or older to enter.